Related Experiment Video
Updated: Mar 20, 2026
08:45
Echocardiographic Assessment Using Subxiphoid-Only Examination for Hypotensive Patients
Published on: April 18, 2025
1.5K
Vasopressors During Sepsis: Selection and Targets
Jean P Gelinas1, James A Russell2
1Centre for Heart Lung Innovation, St. Paul's Hospital, Department of Medicine, University of British Columbia, 1081 Burrard Street, Vancouver, British Columbia V6Z 1Y6, Canada.
Clinics in Chest Medicine
|May 28, 2016
Summary
This review examines key vasopressor and septic shock trials, highlighting urgent resuscitation with fluids, antibiotics, and vasopressors as essential interventions for improved patient care.
Area of Science:
- Critical Care Medicine
- Cardiology
- Infectious Diseases
Background:
- Septic shock management has advanced significantly.
- Standard interventions include fluid resuscitation, vasopressors, and antibiotics.
Purpose of the Study:
- To review pivotal clinical trials on vasopressor use in septic shock.
- To discuss advanced hemodynamic monitoring for non-responders.
Main Methods:
- Literature review of major vasopressor and septic shock trials.
- Analysis of therapeutic strategies including fluid, vasopressors, inotropes, and blood products.
Main Results:
- Established interventions are crucial for initial management.
- Optimizing oxygen delivery through goal-directed therapy is key.
- Advanced monitoring may benefit specific patient groups.
Conclusions:
- Vasopressor selection and hemodynamic optimization remain critical in septic shock care.
- Further research continues to refine treatment protocols for better outcomes.
Related Concept Videos
01:25Cardiopulmonary Resuscitation IV: Pharmacological Management
1.2K
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
1.2K
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
1.4K
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.4K
01:23Antihypertensive Drugs: Vasodilators
2.4K
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
2.4K
01:28Antihypertensive Drugs: Types of β-Blockers
1.9K
β receptors are classified into three subclasses: β1, β2, and β3. β1 receptors are primarily located in the heart and kidneys. When they get activated, they increase heart rate, contractility, and renin release. This process enhances blood pressure and aids in stress management. In contrast, β2 receptors are situated mainly in the lungs, blood vessels, and skeletal muscles. Upon activation, they trigger smooth muscle relaxation, causing bronchodilation and...
1.9K
01:30Adrenergic Agonists: Therapeutic Uses
2.1K
Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
2.1K
01:22Heart Failure Drugs: β-Blockers
1.1K
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
1.1K